Two Sigma Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Two Sigma Investments’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,700	Closed	-$1.55M	–	3042
2024 Q1	$1.55M	Sell	17,700 -100	-0.6%	-$8.95K	﹤0.01%	1679
2023 Q4	$1.72M	Sell	17,800 -166,900	-90%	-$14.8M	﹤0.01%	1709
2023 Q3	$16.3M	Sell	184,700 -81,900	-31%	-$7.29M	0.04%	443
2023 Q2	$23.1M	Buy	266,600 +173,500	+186%	+$16.3M	0.06%	365
2023 Q1	$9.05M	Buy	93,100 +58,400	+168%	+$6.05M	0.03%	627
2022 Q4	$3.59M	Buy	+34,700	New	+$3.26M	0.01%	1020
2021 Q4	–	Sell	-5,000	Closed	-$386K	–	4300
2021 Q3	$386K	Buy	5,000 +300	+6%	+$23.7K	﹤0.01%	3462
2021 Q2	$392K	Buy	+4,700	New	+$373K	﹤0.01%	3295
2020 Q3	–	Sell	-1,700	Closed	-$210K	–	3094
2020 Q2	$210K	Sell	1,700 -4,000	-70%	-$398K	﹤0.01%	2611
2020 Q1	$482K	Buy	+5,700	New	+$491K	﹤0.01%	1952
2019 Q4	–	Sell	-3,700	Closed	-$249K	–	3643
2019 Q3	$249K	Sell	3,700 -13,900	-79%	-$1.07M	﹤0.01%	3069
2019 Q2	$1.51M	Buy	+17,600	New	+$1.51M	0.01%	1627
2019 Q1	–	Sell	-3,000	Closed	-$255K	–	3027
2018 Q4	$255K	Buy	+3,000	New	+$285K	﹤0.01%	2572
2016 Q4	–	Sell	-50,000	Closed	-$4.63M	–	3102
2016 Q3	$4.63M	Buy	50,000 +47,000	+1,567%	+$4.43M	0.02%	917
2016 Q2	$233K	Buy	+3,000	New	+$255K	﹤0.01%	2676

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's BMRN Position: Q1 2026 in Review

Two Sigma Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 36% in Q1 2026, selling an estimated $1.47M and leaving 44,475 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Two Sigma Investments first reported a position in BMRN in Q2 2013 and has held it in 39 quarters since. The position peaked at $82.7M in Q1 2023. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Two Sigma Investments held 44,475 shares of BioMarin Pharmaceuticals worth $2.51M as of Q1 2026.
Two Sigma Investments sold 25,291 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
BioMarin Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2591 holding.
Two Sigma Investments first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
Two Sigma Investments's BioMarin Pharmaceuticals position peaked at $82.7M in Q1 2023.
555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.